CMS Efforts to Lower Drug Costs for Part D Stakeholders Aided by HealthTech On August 28, the Centers for Medicare & Medicaid Services (CMS), the
Medicare Part D is the pharmacy benefit for people on Medicare. It is an essential program giving older populations access to life-saving medications. However, a
In a nation where modern medicine has made remarkable strides, the fact that high prescription prices force people to disregard doctor’s orders is a profoundly
Prescription drug abuse is a pressing public health concern because of the devastating consequences for individuals, families, and communities. Misuse of prescription drugs leads to
The CDC recently released a study that directly ties the cost of medication with nonadherence and poorer health outcomes. The study “Characteristics of Adults Aged
The Centers for Medicare and Medicaid Services (CMS) is proposing a change to self-funded small employers that could roll back some of these protections and undermine state insurance oversight.
A recent study conducted by the CDC, titled “Characteristics of Adults Aged 18–64 Who Did Not Take Medication as Prescribed to Reduce Costs: United States, 2021,” delves into the factors influencing medication nonadherence due to financial constraints.
In the world of healthcare, optimizing medication costs while ensuring patient well-being is a delicate balance. RazorMetrics, a leading healthcare technology company, is revolutionizing this process by facilitating prescription switches through effective communication between prescribers, patients, and pharmacists. Leveraging our proprietary Intervention Codex, we provide cost-effective, therapeutically equivalent alternatives and improve healthcare affordability without compromising quality.
Drug costs are skyrocketing, but why? This is an essential question to ask since we must understand the cause of high drug costs in order to properly address the problem. As someone who has worked in healthcare and life sciences technology for more than twenty-five years, I’ve seen drug costs grow and dominate pharmacy budgets across the United States. Despite substantial technological improvements during this period, drug prices remain unaffordable for many Americans. After extensive contemplation, I’ve concluded that the root causes of high drug costs fall into five categories.
The use of biosimilars is increasing. There are currently 40 already approved by the FDA. Biosimilars are a less expensive version of a brand-name biologic
And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.
